We can help you find what you need. Get in touch with us.
There are today 164 companies plus partners developing 196 drugs targeting liver cancer in development. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 52 drugs. Liver Cancer D....
Drug Delivery | Aug 20th, 2013 | by BioSeeker
Industry : Healthcare
There are today 258 companies plus partners developing 299 drugs targeting pancreatic cancer in development. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 107 drugs. Pancreat....
Drug Delivery | Aug 20th, 2013 | by BioSeeker
Industry : Healthcare
There are today 233 companies plus partners developing 218 peptide drugs in 516 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 124 drugs. Pep....
Drug Delivery | Aug 20th, 2013 | by BioSeeker
Industry : Healthcare
The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The....
Drug Delivery | Aug 20th, 2013 | by BioSeeker
Industry : Healthcare
Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players sales have been eroded by the launch of various LHRH agonist depot formulations. Safety concern....
Drug Delivery | Aug 20th, 2013 | by BioSeeker
Industry : Healthcare